Leukemia Research
Volume 29, Issue 7 , Pages 755-759 , July 2005

Induction of CXC and CC chemokines by all-trans retinoic acid in acute promyelocytic leukemia cells

  • Misako Shibakura

      Affiliations

    • Department of Medical Technology, Faculty of Health Sciences, Okayama University Medical School, 2-5-1 Shikata-cho, Okayama 700-8558, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 86 223 7151x6888; fax: +81 86 222 3717.
    • ,
  • Kenji Niiya

      Affiliations

    • Department of Medicine II, Faculty of Medicine, Okayama University Medical School, 2-5-1 Shikata-cho, Okayama 700-8558, Japan
    • ,
  • Masami Niiya

      Affiliations

    • Department of Medicine II, Faculty of Medicine, Okayama University Medical School, 2-5-1 Shikata-cho, Okayama 700-8558, Japan
    • ,
  • Noboru Asaumi

      Affiliations

    • Department of Medicine II, Faculty of Medicine, Okayama University Medical School, 2-5-1 Shikata-cho, Okayama 700-8558, Japan
    • ,
  • Chikamasa Yoshida

      Affiliations

    • Department of Medicine II, Faculty of Medicine, Okayama University Medical School, 2-5-1 Shikata-cho, Okayama 700-8558, Japan
    • ,
  • Yasunari Nakata

      Affiliations

    • Department of Medical Technology, Faculty of Health Sciences, Okayama University Medical School, 2-5-1 Shikata-cho, Okayama 700-8558, Japan
    • ,
  • Mitsune Tanimoto

      Affiliations

    • Department of Medicine II, Faculty of Medicine, Okayama University Medical School, 2-5-1 Shikata-cho, Okayama 700-8558, Japan

Received 25 May 2004 ,Accepted 2 January 2005.

References 

  1. Tallman MS, Nabhan C, Feusner JH, Rowe JM. Acute promyelocytic leukemia: evolving therapeutic strategies. Blood. 2002;99:759–767
  2. Frankel SR, Eardley A, Lauwers G, Weiss M, Warrell RP. The “retinoic acid syndrome” in acute promyelocytic leukemia. Ann Intern Med. 1992;117:292–296
  3. De Botton S, Dombret H, Sanz M, Miguel JS, Caillot D, Zittoun R, et al. Incidence, clinical features, and outcome of all-trans-retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukaemia. The European APL Group. Blood. 1998;92:2712–2718
  4. Dubois C, Schlageter MH, de Gentile A, Guidez F, Balitrand N, Toubert ME, et al. Hematopoietic growth factor expression and ATRA sensitivity in acute promyelocytic blast cells. Blood. 1994;83:3264–3270
  5. Hsu HC, Tsai WH, Chen PG, Hsu ML, Ho CK, Wang SY. In vitro effect of granulocyte-colony stimulating factor and all-trans retinoic acid on the expression of inflammatory cytokines and adhesion molecules in acute promyelocytic leukemic cells. Eur J Haematol. 1999;63:11–18
  6. Marchetti M, Falanga A, Giovanelli S, Oldani E, Barbui T. All-trans-retinoic acid increases adhesion to endothelium of the human promyelocytic leukaemia cell line NB4. Br J Haematol. 1996;93:360–366
  7. Burn TC, Petrovick MS, Hohaus S, Rollins BJ, Tenen DG. Monocyte chemoattractant protein-1 gene is expressed in activated neutrophils and retinoic acid-induced human myeloid cell lines. Blood. 1994;84:2776–2783
  8. Shibakura M, Niiya K, Kiguchi T, Shinagawa K, Ishimaru F, Ikeda K, et al. Simultaneous induction of matrix metalloproteinase-9 and interleukin 8 by all-trans retinoic acid in human PL-21 and NB4 myeloid leukaemia cells. Br J Haematol. 2002;118:419–425
  9. Lee KH, Chang MY, Ahn JI, Yu DH, Jung SS, Choi JH, et al. Differential gene expression in retinoic acid-induced differentiation of acute promyelocytic leukemia cells, NB4 and HL-60 cells. Biochem Biophys Res Commun. 2002;296:1125–1133
  10. Lanotte M, Martin-Thouvenin V, Najman S, Balerini P, Valensi F, Berger R. NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3). Blood. 1991;77:1080–1086
  11. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning, a laboratory manual. 2nd ed.. New York: Cold Spring Harbor; 1989;
  12. Gianni M, Norio P, Terao M, Falanga A, Marchetti M, Rambaldi A, et al. Effects of dexamethasone on pro-inflammatory cytokine expression, cell growth and maturation during granulocytic differentiation of acute promyelocytic leukemia cells. Eur Cytokine Netw. 1995;6:157–165
  13. Rollins BJ. Chemokines. Blood. 1997;90:909–928
  14. Lalor T, Adams D. The liver: a model of organ-specific lymphocyte recruitment. Expert Rev Mol Med. 2002;2002:1–15
  15. Gerard C, Frossard JL, Bhatia M, Saluja A, Gerard NP, Lu B, et al. Targeted disruption of the beta-chemokine receptor CCR1 protects against pancreatitis-associated lung injury. J Clin Invest. 1997;100:2022–2027
  16. Goodman RB, Strieter RM, Martin DP, Steinberg KP, Milberg JA, Maunder RJ, et al. Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. Am J Respir Crit Care Med. 1996;154:602–611

PII: S0145-2126(05)00042-1

doi: 10.1016/j.leukres.2005.01.005

Leukemia Research
Volume 29, Issue 7 , Pages 755-759 , July 2005

Article Tools

* Image Usage & Resolution